Anti-TNMD monoclonal antibody

Pre-made anti-TNMD monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TNMD/TNMD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2157-Ab-1/ GM-Tg-hg-IP2157-Ab-2Anti-Human TNMD monoclonal antibodyHuman
GM-Tg-rg-IP2157-Ab-1/ GM-Tg-rg-IP2157-Ab-2Anti-Rat TNMD monoclonal antibodyRat
GM-Tg-mg-IP2157-Ab-1/ GM-Tg-mg-IP2157-Ab-2Anti-Mouse TNMD monoclonal antibodyMouse
GM-Tg-cynog-IP2157-Ab-1/ GM-Tg-cynog-IP2157-Ab-2Anti-Cynomolgus/ Rhesus macaque TNMD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2157-Ab-1/ GM-Tg-felg-IP2157-Ab-2Anti-Feline TNMD monoclonal antibodyFeline
GM-Tg-cang-IP2157-Ab-1/ GM-Tg-cang-IP2157-Ab-2Anti-Canine TNMD monoclonal antibodyCanine
GM-Tg-bovg-IP2157-Ab-1/ GM-Tg-bovg-IP2157-Ab-2Anti-Bovine TNMD monoclonal antibodyBovine
GM-Tg-equg-IP2157-Ab-1/ GM-Tg-equg-IP2157-Ab-2Anti-Equine TNMD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2157-Ab-1/ GM-Tg-hg-IP2157-Ab-2; GM-Tg-rg-IP2157-Ab-1/ GM-Tg-rg-IP2157-Ab-2;
GM-Tg-mg-IP2157-Ab-1/ GM-Tg-mg-IP2157-Ab-2; GM-Tg-cynog-IP2157-Ab-1/ GM-Tg-cynog-IP2157-Ab-2;
GM-Tg-felg-IP2157-Ab-1/ GM-Tg-felg-IP2157-Ab-2; GM-Tg-cang-IP2157-Ab-1/ GM-Tg-cang-IP2157-Ab-2;
GM-Tg-bovg-IP2157-Ab-1/ GM-Tg-bovg-IP2157-Ab-2; GM-Tg-equg-IP2157-Ab-1/ GM-Tg-equg-IP2157-Ab-2
Products NameAnti-TNMD monoclonal antibody
Formatmab
Target NameTNMD
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TNMD monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2157-Ag-1Recombinant multi-species TNMD/ BRICD4/ CHM1L protein


    Target information

    Target IDGM-IP2157
    Target NameTNMD
    Gene ID64102,64103,64104,700526,119868217,101085104,781292,100033840
    Gene Symbol and Synonyms1110017I01Rik,BRICD4,CHM1L,TEM,TNMD
    Uniprot AccessionQ9H2S6,Q9ESC2
    Uniprot Entry NameTNMD_HUMAN,TNMD_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000000005
    Target ClassificationN/A

    The target: TNMD, gene name: TNMD, also named as BRICD4, CHM1L, TEM. This gene encodes a protein that is related to chondromodulin-I, which is a cartilage-specific glycoprotein that functions to stimulate chondrocyte growth and to inhibit tube formation of endothelial cells. This protein is also an angiogenesis inhibitor. Genetic variation in this gene is associated with a risk for type 2 diabetes, central obesity and serum levels of systemic immune mediators in a body size-dependent manner. This gene is also a candidate gene for age-related macular degeneration, though a direct link has yet to be demonstrated. [provided by RefSeq, Sep 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.